8.00
0.00
(0.00%)
At close: January 30 at 3:35:05 PM EST
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Salim Dhanji Ph.D. | Chief Exec. Officer and Director | -- | -- | -- |
| Salim Dhanji | CEO & Director | -- | -- | -- |
| Mr. Quinn Martin C.A., CPA | Chief Financial Officer | -- | -- | 1982 |
| Jamil Kassam | Corp. Sec. | -- | -- | -- |
METheraHld
177 Robson Street
Vancouver, BC V6B 0N3
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
Description
ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.
Corporate Governance
METheraHld’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
VRTX.VI Vertex Pharmaceuticals Incorporated
447.90
+5.74%
DRUG.CN Bright Minds Biosciences Inc.
47.59
+6.68%
XSNX NovAccess Global Inc.
0.0003
0.00%
SBM.V Sirona Biochem Corp.
0.0500
0.00%
APS.TO Aptose Biosciences Inc.
0.2550
+2.00%
MDNA.TO Medicenna Therapeutics Corp.
1.3200
0.00%
DTC.CN Defence Therapeutics Inc.
1.0200
-9.73%
PXMD PaxMedica, Inc.
0.0310
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.2300
+2.22%
ONC.TO Oncolytics Biotech Inc.
1.0700
+0.94%